Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025

Rhea-AI Summary

Lifecore Biomedical (NASDAQ: LFCR) will report financial results for the three months ended September 30, 2025 on Thursday, November 6, 2025 after market close.

Management will host a live webcast at 4:30 p.m. Eastern Time the same day to discuss results. To listen live or access the archived webcast (available for 30 days), visit the company’s Investor Events & Presentations page: https://ir.lifecore.com/events-presentations.

Webcast Scheduled for Thursday, November 6 at 4:30 p.m. Eastern

CHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the three months ended September 30, 2025, on Thursday, November 6, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discuss the results.

To listen to the live webcast, or access the archived webcast, please visit the Investor Events & Presentations page of Lifecore’s website at: https://ir.lifecore.com/events-presentations. Following the live webcast, an archived version of the webcast will be available on the company’s website for 30 days.
  
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com 

Tim Brons (Media)
415-675-7402
tbrons@vidasp.com 

Ryan D. Lake (CFO)
Lifecore Biomedical
952-368-6244
ryan.lake@lifecore.com

FAQ

When will Lifecore Biomedical (LFCR) report Q3 2025 results?

Lifecore will report results for the quarter ended September 30, 2025 on Thursday, November 6, 2025 after market close.

What time is the Lifecore (LFCR) webcast on November 6, 2025?

The live webcast begins at 4:30 p.m. Eastern Time on November 6, 2025.

Where can investors access the Lifecore (LFCR) live webcast and replay?

Access the live webcast and archived replay at https://ir.lifecore.com/events-presentations; the archive will be available for 30 days after the live event.

Will Lifecore (LFCR) management discuss the Q3 2025 results live?

Yes. Lifecore’s senior management team will host the webcast to discuss the Q3 2025 results at the scheduled time.

Is the Lifecore (LFCR) archived webcast available immediately after the live event?

Yes. An archived version will be posted on the company’s website following the live webcast and remain available for 30 days.